Skip to main content

Female Surgeons Have Lower Rates of Adverse Postoperative Outcomes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Sept. 1, 2023 -- Patients treated by female surgeons have a lower likelihood of adverse postoperative outcomes, including death, at 90 days and one year postsurgery, according to a study published online Aug. 30 in JAMA Surgery.

Christopher J.D. Wallis, M.D., Ph.D., from Mount Sinai Hospital in Toronto, and colleagues examined whether surgeon sex is associated with 90-day and one-year outcomes among patients undergoing common surgeries. The analysis included more than 1.16 million Canadian adults undergoing one of 25 common elective or emergent surgeries from 2007 through 2019.

The researchers found that overall, 14.3 percent of patients had one or more adverse postoperative outcomes at 90 days and 25.0 percent had one or more adverse postoperative outcomes one year postsurgery. For the composite of death, readmission, or complication, rates were higher among patients treated by male than female surgeons at both 90 days (13.9 versus 12.5 percent; adjusted odds ratio [aOR], 1.08; 95 percent confidence interval [CI], 1.03 to 1.13) and one year (25.0 versus 20.7 percent; aOR, 1.06; 95 percent CI, 1.01 to 1.12), when adjusting for patient, procedure, surgeon, anesthesiologist, and hospital characteristics. Findings were similar for mortality at 90 days (0.8 versus 0.5 percent; aOR, 1.25; 95 percent CI, 1.12 to 1.39) and one year (2.4 versus 1.6 percent; aOR, 1.24; 95 percent CI, 1.13 to 1.36).

"These findings further support differences in patient outcomes based on physician sex that warrant deeper study regarding underlying causes and potential solutions," write the authors.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...

Few Patients With Positive Margins After Basal Cell Excision Have Recurrence

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...

Small Number of Procedures Account for Large Number of Opioid Prescriptions

FRIDAY, June 28, 2024 -- A small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.